Login
|
Register
News
Media
Insights
Peer Exchange
OncNurse TV
Webinars
Podcasts
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Blood Cancers
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Drug Safety
Skin Cancer/Melanoma
Brain Cancer
Childhood/AYA Cancer
Head and Neck Cancers
Adverse Event Management
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Register now to learn about a new option for relapsed or refractory follicular lymphoma
AIM at Melanoma
AIM at Melanoma is globally engaged and locally invested in advancing the battle against melanoma through groundbreaking research, legislative reform, education, and patient and caregiver support.
Surviving Stage IV Melanoma With Vigilance and Hope
Thursday, February 12, 2015
Tweets by @cure_magazine
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.